Tirzepatide, which already redefined what weight loss medications could achieve, delivered approximately 20.9% in similar timeframes
Tirzepatide Most scientifically supported peptide for weight loss Pros Dual-agonist action for improved efficacy Has led to greater weight loss in clinical studies compared to semaglutide Usually only a once-a-week administration Cons Potentially higher side effect risk than semaglutide Less available online than semaglutide Tirzepatide is a dual agonist, which means it simulates the activities of not one but two hormones: GLP-1: stimulates insulin secretion, inhibits glucagon secretion, slows digestion, and increases feelings of fullness7 GIP: stimulates insulin secretion and helps to reduce fat accumulation14 Thanks to tirzepatides two-part action against obesity factors, it has risen to the top of the hierarchy among all therapeutic peptides currently used for weight loss
10.3389/fnins.2019.01026 Front
Your Annual Physical Manual Data Processing Guesswork Trend Detection Once-a-year physical Reactive, tested when sick No data between visits Once a year testing Delayed Results One-size dosing, set and forget Real-Time Trend Insights Daily smart-device data Automated Data Sync Quarterly Biomarker Tests Optimal, personalized targets Plain-language AI insights Medications titrated to your data Built to extend healthspan Frequently Asked Questions Clarity before you commit Answers on setup, scale, and support to remove blockers.
Chronic high prolactin levels impact on gene expression at discrete hypothalamic nuclei involved in food intake
An investigation of the antidepressant-like effect of Jiaotaiwan in rats by nontargeted metabolomics based on ultra-high-performance liquid chromatography quadrupole time-of-flight mass spectrometry